Clone Algo Technologies Inc
Clone Algo Technologies Inc., a technology company, develops algorithms and risk management systems based on artificial intelligence. Its products include Clone Algo, a social investment network app that enables users to clone trades from master accounts to users own account with connected brokers, banks, and hedge funds using algorithms, and advanced cloning and non-predictive timing technology;… Read more
Clone Algo Technologies Inc (CATI) - Net Assets
Latest net assets as of March 2015: $1.80 Million USD
Based on the latest financial reports, Clone Algo Technologies Inc (CATI) has net assets worth $1.80 Million USD as of March 2015.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.25 Million) and total liabilities ($455.42K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.80 Million |
| % of Total Assets | 79.77% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 179.65 |
Clone Algo Technologies Inc - Net Assets Trend (2013–2021)
This chart illustrates how Clone Algo Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Clone Algo Technologies Inc (2013–2021)
The table below shows the annual net assets of Clone Algo Technologies Inc from 2013 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-12-31 | $-159.36K | -2.72% |
| 2020-12-31 | $-155.15K | -182.07% |
| 2019-12-31 | $-55.00K | -439.61% |
| 2014-12-31 | $16.20K | -80.31% |
| 2013-12-31 | $82.27K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Clone Algo Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 266210200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2021)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $76.06K | % |
| Other Comprehensive Income | $2.51 Million | % |
| Total Equity | $-159.36K | 100.00% |
Clone Algo Technologies Inc Competitors by Market Cap
The table below lists competitors of Clone Algo Technologies Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
G3 Exploration Ltd
STU:G3J
|
$2.93K |
|
QUICKSTEP HLDGS
BE:QIS
|
$2.93K |
|
TIANJIN DEVL
MU:TJN
|
$2.93K |
|
RUOC
STU:RUOC
|
$2.93K |
|
LAVIDE HOLDING
BE:QU71
|
$2.92K |
|
GeneThera Inc
PINK:GTHR
|
$2.92K |
|
Ingdan Inc
STU:7C3
|
$2.92K |
|
Automobile & PCB Inc.
KQ:015260
|
$2.92K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Clone Algo Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from -155,145 to -159,361, a change of -4,216.
- Net loss of 104,216 reduced equity.
- Other comprehensive income increased equity by 99,999.
- Other factors increased equity by 1.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-104.22K | -65.4% |
| Other Comprehensive Income | $100.00K | +62.75% |
| Other Changes | $1.00 | +0.0% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Clone Algo Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-0.01 | $0.30 | x |
| 2020-12-31 | $0.00 | $0.30 | x |
| 2021-12-31 | $0.00 | $0.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Clone Algo Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-110.59%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -33.86% | 0.00% | 0.00x | 1.05x | $-36.09K |
| 2014 | -519.08% | 0.00% | 0.00x | 1.30x | $-85.69K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-49.50K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $1.99K |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-88.28K |
Industry Comparison
This section compares Clone Algo Technologies Inc's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $-56,363,212
- Average return on equity (ROE) among peers: -7.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Clone Algo Technologies Inc (CATI) | $1.80 Million | -33.86% | 0.25x | $2.93K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $-22.04K | 0.00% | 0.00x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $5.32 Million | -71.85% | 3.84x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $-185.37K | 0.00% | 0.00x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-181.19K | 0.00% | 0.00x | $14.73K |
| ACRO Biomedical Co Ltd (ACBM) | $-14.79K | 0.00% | 0.00x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-1.02K | 0.00% | 0.00x | $3.15K |